• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.30 0.30
(0.00%)
Sensex
83,485.38 42.88
( 0.05%)
Bank Nifty
56,949.20 -82.70
( -0.15%)
Nifty IT
38,866.95 -299.60
( -0.76%)
Global Indices
Nasdaq
44,419.70 -429.83
(-0.96%)
Dow Jones
6,250.56 -49.79
(-0.79%)
Hang Seng
39,701.12 113.44
(0.29%)
Nikkei 225
8,806.53 -16.38
(-0.19%)
Forex
USD-INR
84.98 -0.45
(-0.53%)
EUR-INR
100.05 -0.56
(-0.55%)
GBP-INR
115.91 -0.68
(-0.58%)
JPY-INR
0.59 0.00
(-0.66%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
276.1595271
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
90.8
8666.72
EPS(TTM)
Face Value()
Div & Yield %
9.76
1
0.11
 

growington ventures india ltd
Oriental Rail Infra hits the floor after Q4 PAT slumps 29% QoQ to Rs 5 cr
May 28,2025

On a year-on-year (YoY) basis, the company’s net profit rose 22.88% in Q4 FY25, despite an 18.50% decline in revenue. Profit before tax (PBT) zoomed 108.88% YoY to Rs 11.99 crore in Q4 FY25.

Total expenses fell 21.59% YoY to Rs 131.13 crore in Q4 FY25. The cost of material consumed stood at Rs 111.09 crore (down 13.97% YoY) while employee benefit expenses was at Rs 7.94 crore (up 32.55% YoY), and finance cost stood at Rs 6.21 crore (up 6.15% YoY).

On a full year basis, the company’s consolidated net profit fell 2.63% to Rs 29.21 crore despite 14.44 rise in revenue in operations to Rs 602.21 crore in FY25 over FY24.

Meanwhile, the board has recommended a dividend of Rs 0.10 per equity share of face value Rs 1 each (i.e., 10%) for the financial year ended 31 March 2025, subject to shareholder approval at the upcoming annual general meeting.

Oriental Rail Infrastructure is engaged in the manufacturing and supply of several diversified railway products and items for Indian Railways and other related industries. Its products include seat & berth, recorn, compreg board & articles thereof, furniture & parts, coated upholstery fabric, plywood, phenolic resin & hardener, silicon foam, etc.